| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |